000 | 01930 a2200529 4500 | ||
---|---|---|---|
005 | 20250513142932.0 | ||
264 | 0 | _c19980521 | |
008 | 199805s 0 0 eng d | ||
022 | _a0025-732X | ||
040 |
_aNLM _beng _cNLM |
||
245 | 0 | 0 |
_aAdvice for travelers. _h[electronic resource] |
260 |
_bThe Medical letter on drugs and therapeutics _cApr 1998 |
||
300 |
_a47-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAnti-Infective Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntidiarrheals _xtherapeutic use |
650 | 0 | 4 |
_aBacterial Vaccines _xtherapeutic use |
650 | 0 | 4 |
_aCholera _xprevention & control |
650 | 0 | 4 |
_aCiprofloxacin _xtherapeutic use |
650 | 0 | 4 |
_aDiarrhea _xdrug therapy |
650 | 0 | 4 |
_aDiphtheria Toxoid _xtherapeutic use |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aEncephalitis, Japanese _xprevention & control |
650 | 0 | 4 | _aEscherichia coli Infections |
650 | 0 | 4 |
_aHepatitis A _ximmunology |
650 | 0 | 4 | _aHepatitis A Vaccines |
650 | 0 | 4 |
_aHepatitis B _xprevention & control |
650 | 0 | 4 |
_aHepatitis B Vaccines _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunization |
650 | 0 | 4 |
_aLoperamide _xtherapeutic use |
650 | 0 | 4 |
_aMalaria _xprevention & control |
650 | 0 | 4 |
_aMeasles Vaccine _xtherapeutic use |
650 | 0 | 4 |
_aMefloquine _xadministration & dosage |
650 | 0 | 4 |
_aMeningitis, Meningococcal _xprevention & control |
650 | 0 | 4 | _aMeningococcal Vaccines |
650 | 0 | 4 |
_aPoliovirus Vaccine, Oral _xtherapeutic use |
650 | 0 | 4 | _aRabies Vaccines |
650 | 0 | 4 |
_aTetanus Toxoid _xtherapeutic use |
650 | 0 | 4 | _aTravel |
650 | 0 | 4 | _aTyphoid-Paratyphoid Vaccines |
650 | 0 | 4 | _aVaccination |
650 | 0 | 4 |
_aViral Hepatitis Vaccines _xtherapeutic use |
650 | 0 | 4 |
_aViral Vaccines _xtherapeutic use |
650 | 0 | 4 |
_aYellow fever virus _ximmunology |
773 | 0 |
_tThe Medical letter on drugs and therapeutics _gvol. 40 _gno. 1025 _gp. 47-50 |
|
999 |
_c9557753 _d9557753 |